Dr. Terence Ching

Terence Ching, PhD (he/him) is a Yale-, Dartmouth-, and UConn-trained clinical psychologist licensed in CT.

Dr. Ching has vast academic and clinical expertise in mood, anxiety, and trauma-based disorders, especially obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).

Dr. Ching is also an Instructor on the faculty of the Department of Psychiatry at the Yale School of Medicine. There, he leads psychedelic clinical trials (namely, psilocybin) for OCD, depression, and other disorders in the Yale Program for Psychedelic Science. There, Dr. Ching assumes the role of Director of Psychedelic Training, pioneering the training and supervision of numerous facilitators who work with study participants in psychedelic dosing sessions.

In the psychedelic therapy space, Dr. Ching is an extensively published global leader in culturally attuned, queer- and trans-affirming, and ethically rigorous care of individuals experiencing altered states of consciousness.

Lastly, Dr. Ching is an internationally sought after scientific speaker. He has significant consulting experience in various aspects of psychedelic research and practice, having trained hundreds of study therapists for multiple companies who have achieved FDA Breakthrough Therapy designation in their drug development programs.

Dr. Ching specializes in high-quality, evidence-based, integrative, culturally attuned, and affirming cognitive-behavior therapy (CBT) and acceptance and commitment therapy (ACT) in his work with clients.

Dr. Ching also translates his psychedelic therapy expertise to integration services for clients seeking to collaboratively process previous profound psychedelic/ketamine experiences, in service of meaningful integration of these experiences into their lives moving forward.

You will first complete a comprehensive intake with Dr. Ching to arrive at a better understanding of your mental health history and your current priorities, in order to best inform therapy.

Therapy then begins at a weekly cadence over 60-min sessions, with an initial collaborative treatment planning phase (1-2 sessions) to establish details of current problems and corresponding goals. Regular sessions follow, during which integrative CBT and ACT skills and strategies are learned, absorbed, and enacted, in order to maintain benefits post-treatment. The course of treatment may vary depending on your goals and progress, ranging from 18-25 weekly sessions, up to a few years.

Psychedelic/ketamine integration is also available if appropriate. This may occur at separate regular sessions, or integrated into your current course of treatment, whichever makes the most clinical sense. Note that this service does not involve the administration of psychedelics, ketamine, or other psychoactive agents. Rather, the emphasis is on collaboratively processing previous profound psychedelic/ketamine experiences in service of integrating meaningful insights into one's life moving forward. Dr. Ching may also incorporate CBT, ACT, and harm reductionist principles into the integration process.